SCRIVO, Rossana et al. Secukinumab Treatment in Patients with Spondyloarthritis and Concomitant Demyelinating Disease: Rationale of IL-17 Inhibition and Clinical Outcome. Archives of Clinical and Medical Case Reports, [S. l.], v. 6, n. 5, p. 660–668, 2022. Disponível em: https://fortunejournals.org/ojs/index.php/acmcr/article/view/22670. Acesso em: 15 jun. 2026.